FDA approves first RSV vaccine for at-risk adults in their 50s
The RSV vaccine by GSK was previously approved only for adults 60 and older.
Source: cbsnews.com
Phil Dormitzer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phil Dormitzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phil Dormitzer Today - Breaking & Trending Today
FDA approves GSK RSV vaccine for adults 50 to 59
The FDA's expanded approval could help GSK maintain its dominance in the RSV market, which includes shots from Pfizer and Moderna.
Source: cnbc.com
Recombinant Zoster Vaccine Demonstrates High Protection Against Shingles in Adult Patients
The recombinant zoster vaccine demonstrated a 79.7% efficacy in patients aged 50 years and older cumulatively within the 6- to 11-year period after vaccination.
Source: pharmacytimes.com
'Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk'
GSK scientists spent decades researching respiratory syncytial virus to understand how to prevent the disease it causes.
Source: gsk.com
Vaccines: A Golden Age of Shots Is Here. What It Means for You.
Pharamaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.
Source: marketwatch.com